Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Depress Anxiety. 2018 May 10;35(7):658–667. doi: 10.1002/da.22772

Table 3.

Neuropsychological and neuroimaging factor effects on recurrence

Neuropsychological Assessments Recurrent Non-recurrent Wald X2 p value
MMSE N=135
28.1 (2.0)
N=102
28.2 (2.4)
1.60 0.2061
Episodic Memory N=113
−0.026 (0.798)
N = 77
0.006 (0.686)
1.89 0.1697
Executive Function N=110
−0.090 (0.943)
N = 76
−0.055 (0.850)
1.86 0.1726
Verbal Fluency N=112
−0.047 (0.851)
N=77
−0.103 (0.874)
0.01 0.9558
Working Memory N=104
−0.062 (0.829)
N=74
−0.002 (0.758)
0.52 0.4688
Neuroimaging Measures
White Matter Hyperintensity Volume N=59
6.21 (8.93)
N=57
5.83 (8.96)
0.09 0.7613
Hippocampus, left N=47
2.98 (0.54)
N=33
2.94 (0.37)
0.75 0.3867
Hippocampus, right N=47
3.01 (0.47)
N=33
3.11 (0.34)
1.54 0.2151
Lateral Ventricles N=59
36.28 (21.33)
N=57
39.59 (26.21)
0.50 0.4795
Total Cerebral Gray Matter Volume N=59
591.0 (87.5)
N=57
573.2 (82.6)
3.76 0.0525
Total Cerebral Volume N=59
1148.2 (132.9)
N=57
1163.1 (139.9)
0.15 0.6965

Neuropsychological test models examine z-transformed cognitive domain scores, controlling for age, sex, and education. Neuroimaging measures are presented in milliliters and models control for age, sex, and total cerebral volume, except for models focusing solely on total cerebral volume that control only for age and sex. Sample size included for each model due to missing data. MMSE = Mini-mental state exam.